Insurance Denials and Appeals

Why almost everything gets denied

Regenerative medicine sits in a coverage gap: not experimental enough to qualify for research-cost coverage under some plans, not established enough to be recognized as standard of care by most private insurers or Medicare. The categorical result is denial. Even PRP for well-studied orthopedic indications is inconsistently covered domestically in the U.S. Cell therapy for international treatment is almost universally excluded.

Framing this honestly upfront saves patients a lot of energy: assume no coverage, and treat any partial reimbursement as a bonus rather than a plan.

What can sometimes be recovered

Diagnostic workup and post-treatment imaging

MRI, X-ray, blood work, and consultations with U.S.-licensed providers before or after treatment are often covered under normal outpatient benefits — regardless of what you did between them. This is where the largest recoverable amount usually sits.

HSA and FSA reimbursement

Health savings accounts and flexible spending accounts frequently allow reimbursement for medical expenses that are IRS-qualified, even when insurance does not cover them. Whether a specific regenerative procedure qualifies depends on IRS definitions of "medical care" — generally, procedures with a diagnosis and medical rationale can qualify. Documentation matters. You will need itemized invoices, a diagnosis code from your treating provider, and often a letter of medical necessity.

FMLA and short-term disability

Not reimbursement of the therapy itself, but leave protection while recovering. If your therapy is for a diagnosed condition and your U.S. provider can certify medical necessity for recovery time, FMLA can cover unpaid protected leave.

What to document from the start

• All physician recommendations, referrals, and imaging that led to the decision to pursue therapy.
• Itemized invoices from the treating clinic in English (not just a total).
• Written treatment protocol including cell source, dose, and route of administration.
• Discharge summary or treatment report.
• Follow-up imaging and clinical assessments post-treatment.

Without documentation in a form your insurer can process, appeals fail before they start.

How appeals actually work

Most private insurers have a two-tier internal appeal process, followed by external independent review if internal appeals fail. Each stage has strict deadlines — usually 30 to 180 days from denial. Missing a deadline forfeits that appeal level.

What a defensible appeal argues

• Medical necessity supported by physician documentation of failed conservative treatments.
• The specific therapy has published evidence in peer-reviewed journals for the indication (with citations, not vague claims).
• The cost of denied therapy is comparable to or less than the covered alternative (often surgery), if that framing applies.
• Alternative interventions have specific risks the patient's clinical picture makes preferable to avoid.

The framing that consistently loses: "this therapy worked and I want reimbursement." Insurers do not reimburse on retrospective outcomes; they reimburse on medical-necessity criteria applied at the time of the decision.